(e) On June 19, 2009, the stockholders of ARIAD Pharmaceuticals, Inc. (the "Company") approved, at the Company's 2009 Annual Meeting of Stockholders, (i) an amendment to the Company's 2006 Long-Term Incentive Plan, as previously amended (the "Incentive Plan"), to increase the number of shares of common stock available for issuance under the Incentive Plan by 7,000,000 shares and to remove the limitation on the number of full-value awards issuable under the plan; and (ii) an amendment to the Company's Amended and Restated 1997 Employee Stock Purchase Plan, as previously amended (the "ESPP"), to increase the number of shares of common stock available for issuance under the ESPP by 750,000 shares.

The Incentive Plan and the ESPP, each as amended, are attached hereto as exhibits to this Current Report on Form 8-K and are being filed pursuant to this Item 5.02 as Exhibits 99.1 and 99.2, respectively, to this Current Report on Form 8-K.

(d) Exhibits.

Exhibit
Number     Description
------     -----------

99.1+      ARIAD Pharmaceuticals, Inc. 2006 Long-Term Incentive Plan, as amended
           (filed as Appendix A to the Registrant's Definitive Proxy Statement
           on Schedule 14A (File No. 000-21696) filed with the Securities and
           Exchange Commission on April 30, 2009 and incorporated herein by
           reference)

99.2+      Amended and Restated ARIAD Pharmaceuticals, Inc. 1997 Employee Stock
           Purchase Plan (filed as Appendix B to the Registrant's Definitive
           Proxy Statement on Schedule 14A (File No. 000-21696) filed with the
           Securities and Exchange Commission on April 30, 2009 and incorporated
           herein by reference)

(+) Management contract or compensatory plan or arrangement.